Facial Aesthetics Market Size - By Product, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Global Facial Aesthetics Market Overview:
According to SPER Market Research, the Global Facial Aesthetics Market is estimated to reach USD 31.04 billion by 2032 with a CAGR of 15.72%. A non-invasive aesthetic process called facial aesthetics is used to treat skin issues such scars, acne, hyperpigmentation, wrinkles, dark skin, and stretch marks. Various facial aesthetic procedures, including microdermabrasion, chemical peels, dermal fillers, botulinum toxin, and cosmetic implants, are used to enhance aesthetic appeal.
Impact of COVID-19 on the Global Facial Aesthetics Market
It is projected that the COVID-19 epidemic will negatively affect the development of the global face aesthetics market. To boost hospital capacity for COVID-19 patients, a number of clinics and hospitals were reorganized. Surgery that wasn't absolutely necessary was postponed because of the pandemic. The non-emergency nature of facial aesthetics procedures severely limited the earnings of aesthetic businesses.
Scope of the Report:
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032
Segments covered By Product, By Application, By End User.
Regions covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Candela Syneron, Evolus Inc, Sinclair Pharmaceuticals Limited, Abbvie Inc, Anika Therapeutics, Bausch Health Companies Inc, Cutera Inc, Cynosure.
Global Facial Aesthetics Market Segmentation:
By Product:Based on the Product, Global Facial Aesthetics Market is segmented as; Dermal Fillers (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-lactic Acid, Polymethyl- methacrylate Microspheres, Others), Botulinum Toxin, Microdermabrasion, Chemical Peels, Others.
By Application:Based on the Application, Global Facial Aesthetics Market is segmented as; Facial Line Correction Treatment, Scar Treatment, Lip Enhancement, Restoration of Volume/Fullness, Others.
By Region:North America owns the high share of this request; the major factors of the request's growth in the region are the adding prevalence of habitual ails, the growing quantum of drug conventions brought on by the region's fleetly growing population, and the expansion of crucial request actors in the area.
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER’s internal database
- 2.1.4 Premium insight from KOL’s
- 2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3 Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Facial Aesthetics Market
- 5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
- 5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
- 5.3. PORTER’S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
- 5.4. Heat map analysis
- 6. Global Facial Aesthetics Market, By Product, 2019-2032 (USD Million)
- 6.1. Dermal Fillers
- 6.1.1. Hyaluronic Acid
- 6.1.2. Calcium Hydroxyapatite
- 6.1.3. Poly-L-lactic Acid
- 6.1.4. Polymethyl- methacrylate Microspheres
- 6.1.5. Others
- 6.2. Botulinum Toxin
- 6.3. Microdermabrasion
- 6.4. Chemical Peels
- 6.5. Others
- 7. Global Facial Aesthetics Market, By Application, 2019-2032 (USD Million)
- 7.1. Facial Line Correction Treatment
- 7.2. Scar Treatment
- 7.3. Lip Enhancement
- 7.4. Restoration of Volume/Fullness
- 7.5. Others
- 8. Global Facial Aesthetics Market, By End User, 2019-2032 (USD Million)
- 8.1 Specialty & Dermatology Clinics
- 8.2 Hospitals
- 8.3 Others
- 9. Global Facial Aesthetics Market, By Region, 2019-2032 (USD Million)
- 9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
- 9.2 Europe
- 9.2.1 Germany
- 9.2.2 United Kingdom
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Rest of Europe
- 9.3 Asia-Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
- 9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Rest of South America
- 9.5 Middle East & Africa
- 9.5.1 Kingdom of Saudi Arabia
- 9.5.2 United Arab Emirates
- 9.5.3 Rest of Middle East & Africa
- 10. Company Profiles
- 10.1. Candela Syneron
- 10.1.1 Company details
- 10.1.2 Financial outlook
- 10.1.3 Product summary
- 10.1.4 Recent developments
- 10.2. Evolus Inc
- 10.2.1 Company details
- 10.2.2 Financial outlook
- 10.2.3 Product summary
- 10.2.4 Recent developments
- 10.3. Sinclair Pharmaceuticals Limited
- 10.3.1 Company details
- 10.3.2 Financial outlook
- 10.3.3 Product summary
- 10.3.4 Recent developments
- 10.4. Abbvie Inc
- 10.4.1 Company details
- 10.4.2 Financial outlook
- 10.4.3 Product summary
- 10.4.4 Recent developments
- 10.5. Anika Therapeutics
- 10.5.1 Company details
- 10.5.2 Financial outlook
- 10.5.3 Product summary
- 10.5.4 Recent developments
- 10.6. Bausch Health Companies Inc
- 10.6.1 Company details
- 10.6.2 Financial outlook
- 10.6.3 Product summary
- 10.6.4 Recent developments
- 10.7. Cutera Inc
- 10.7.1 Company details
- 10.7.2 Financial outlook
- 10.7.3 Product summary
- 10.7.4 Recent developments
- 10.8. Cynosure
- 10.8.1 Company details
- 10.8.2 Financial outlook
- 10.8.3 Product summary
- 10.8.4 Recent developments
- 10.9. Fotona D.O.O
- 10.9.1 Company details
- 10.9.2 Financial outlook
- 10.9.3 Product summary
- 10.9.4 Recent developments
- 10.10. Galderma Laboratories
- 10.10.1 Company details
- 10.10.2 Financial outlook
- 10.10.3 Product summary
- 10.10.4 Recent developments
- 10.11. Ipsen
- 10.11.1 Company details
- 10.11.2 Financial outlook
- 10.11.3 Product summary
- 10.11.4 Recent developments
- 10.12. Johnson and Johnson
- 10.12.1 Company details
- 10.12.2 Financial outlook
- 10.12.3 Product summary
- 10.12.4 Recent developments
- 10.13. Merz Pharma
- 10.13.1 Company details
- 10.13.2 Financial outlook
- 10.13.3 Product summary
- 10.13.4 Recent developments
- 10.14. Revance Therapeutics.
- 10.14.1 Company details
- 10.14.2 Financial outlook
- 10.14.3 Product summary
- 10.14.4 Recent developments
- 10.15. Teoxane
- 10.15.1 Company details
- 10.15.2 Financial outlook
- 10.15.3 Product summary
- 10.15.4 Recent developments
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook